|Articles|September 17, 2014
ACRO Survey Shows Strong Growth of CRO Industry
Members of the Association of Clinical Research Organizations have more than doubled in size in the past 10 years
Advertisement
Members of the Association of Clinical Research Organizations (ACRO) have more than doubled in size in the past 10 years and now employ more than 100,000 research professionals worldwide with a global payroll of nearly $6 billion. Over the same period, member company revenues have increased 180% (10.8% CAGR) to an estimated $14.2 billion, or approximately two-thirds of contract biopharmaceutical development spending, demonstrating the strong demand for CRO services by pharmaceutical, biotech and medical device companies.
Other key findings from the member survey include:
- Among the most researched indications by CROs are, breast cancer, Alzheimer’s Disease, hepatitis, diabetes, asthma, hypertension, and vaccines
- On average, each ACRO member works with more than 500 research sponsors and approximately 27,000 research sites annually
- ACRO members delivered more than 100 million central laboratory test results and managed more than 1 million square feet of lab space in 13 countries
- The top US states for CRO employment are North Carolina, Pennsylvania, Massachusetts, New Jersey, Texas and California; the top European locations for CRO employment are the United Kingdom, Germany, France and Spain
Throughout the next month, ACRO will be unveiling a series of case studies that highlight CRO innovation, as well as a video series focusing several of these topics.
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5